ANIX
Anixa Biosciences Inc
2.80$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | – | |
| 54.2% | 39.4% | 72.5% | 28.8% | 98.3% | 66.5% | – | 75.2% | 0.0% | 76.7% | – | – | |
| 45.8% | 60.6% | 27.5% | 71.2% | 1.7% | 33.5% | – | 24.8% | 100.0% | 23.3% | – | – | |
| 32.4% | 7.7% | 518.8% | 440.7% | 612.4% | 2,189.4% | – | 1,208.9% | 0.3% | 2,271.0% | – | – | |
| 174.8% | 59.6% | 903.3% | 1,216.7% | 621.3% | 2,265.1% | – | 1,381.5% | 0.3% | 2,995.7% | – | – | |
| 183.3% | 70.8% | 1,530.5% | 1,747.2% | 1,233.7% | 4,789.5% | – | 2,590.5% | 0.6% | 5,266.7% | – | – | |
| -137.5% | -10.2% | -1,503.0% | -1,676.0% | -1,232.0% | -4,756.0% | – | -2,565.6% | -0.6% | -5,243.3% | – | – | |
| 34.5% | 4.9% | 173.3% | 138.1% | 0.0% | 0.0% | – | 0.1% | 0.0% | – | – | – | |
| -261.9% | -14.9% | -1,672.1% | -1,381.8% | -1,280.3% | -4,727.5% | – | -2,564.0% | -0.6% | -4,728.6% | – | – | |
| 34.5% | 0.2% | 4.2% | 138.1% | 26.1% | 70.3% | – | -35.4% | 0.0% | -56.7% | – | – | |
| -261.9% | -14.9% | -1,672.1% | -1,381.8% | -1,258.1% | -4,658.8% | – | -2,528.6% | -0.6% | -4,671.9% | – | – | |
| -218.9% | -6.5% | -1,379.3% | -1,142.1% | -1,249.4% | -4,402.0% | – | -2,554.9% | -0.6% | -4,706.7% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.